Tanja Jesenko

538 total citations
35 papers, 381 citations indexed

About

Tanja Jesenko is a scholar working on Biotechnology, Molecular Biology and Oncology. According to data from OpenAlex, Tanja Jesenko has authored 35 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biotechnology, 17 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Tanja Jesenko's work include Microbial Inactivation Methods (21 papers), CRISPR and Genetic Engineering (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Tanja Jesenko is often cited by papers focused on Microbial Inactivation Methods (21 papers), CRISPR and Genetic Engineering (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Tanja Jesenko collaborates with scholars based in Slovenia, United States and Italy. Tanja Jesenko's co-authors include Maja Čemažar, Gregor Serša, Boštjan Markelc, Cvetka Grašič Kuhar, Maša Bošnjak, Urška Kamenšek, Primož Strojan, Loreé C. Heller, Julie Gehl and Stine K. Frandsen and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Tanja Jesenko

31 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Jesenko Slovenia 12 183 137 126 92 86 35 381
C. Calvet France 8 230 1.3× 149 1.1× 184 1.5× 173 1.9× 121 1.4× 18 528
Xiangyi Shi China 10 50 0.3× 164 1.2× 70 0.6× 44 0.5× 156 1.8× 15 407
Emanuele Dragonetti Italy 9 79 0.4× 135 1.0× 93 0.7× 45 0.5× 50 0.6× 13 319
Tahmineh Darvishi Germany 4 41 0.2× 235 1.7× 407 3.2× 178 1.9× 99 1.2× 7 585
Zhuolong Zhou China 8 26 0.1× 151 1.1× 138 1.1× 86 0.9× 80 0.9× 15 361
Bernadette Marrero United States 11 45 0.2× 130 0.9× 74 0.6× 57 0.6× 149 1.7× 14 375
Zofia Pilch Poland 10 21 0.1× 110 0.8× 177 1.4× 63 0.7× 182 2.1× 21 367
Guan Jiang China 6 24 0.1× 263 1.9× 209 1.7× 114 1.2× 109 1.3× 9 497
A Godál Norway 15 187 1.0× 178 1.3× 86 0.7× 84 0.9× 307 3.6× 28 526
Joshua W. Henshaw United States 10 124 0.7× 306 2.2× 390 3.1× 121 1.3× 50 0.6× 15 580

Countries citing papers authored by Tanja Jesenko

Since Specialization
Citations

This map shows the geographic impact of Tanja Jesenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Jesenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Jesenko more than expected).

Fields of papers citing papers by Tanja Jesenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Jesenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Jesenko. The network helps show where Tanja Jesenko may publish in the future.

Co-authorship network of co-authors of Tanja Jesenko

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Jesenko. A scholar is included among the top collaborators of Tanja Jesenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Jesenko. Tanja Jesenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Strojan, Primož, Tanja Jesenko, Aleš Grošelj, et al.. (2025). Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region. European Journal of Surgical Oncology. 51(5). 109574–109574. 4 indexed citations
3.
Resnik, Nataša, Daša Zupančič, Maruša Debeljak, et al.. (2025). The role of focal adhesion kinase in bladder cancer: translation from in vitro to ex vivo human urothelial carcinomas. Radiology and Oncology. 59(3). 349–367.
4.
Jesenko, Tanja, et al.. (2025). Effective targeting of E2F1 transcription factor via siRNA gene electrotransfer in HT-29 colorectal carcinoma xenografts. Bioelectrochemistry. 165. 108994–108994. 1 indexed citations
5.
Kavčič, Marko, et al.. (2024). The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia. Radiology and Oncology. 58(1). 133–144. 1 indexed citations
6.
Kos, Špela, Tanja Jesenko, & Tanja Blagus. (2024). In Vivo Wound Healing Model for Characterization of Gene Electrotransfer Effects in Mouse Skin. Methods in molecular biology. 2773. 87–96. 2 indexed citations
7.
Trotovšek, Blaž, et al.. (2024). Electrochemotherapy combined with immunotherapy – a promising potential in the treatment of cancer. Frontiers in Immunology. 14. 1336866–1336866. 12 indexed citations
8.
Kamenšek, Urška, Maja Čemažar, Simona Kranjc, et al.. (2023). What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine. Pharmaceutics. 15(7). 1981–1981. 1 indexed citations
9.
Markelc, Boštjan, et al.. (2023). Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells. Vaccines. 11(5). 925–925. 14 indexed citations
10.
Jesenko, Tanja, Simona Kranjc, Maja Čemažar, et al.. (2023). Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Pharmaceutics. 15(4). 1249–1249. 7 indexed citations
11.
Kuhar, Cvetka Grašič, Marina Mencinger, Tanja Ovčariček, et al.. (2023). Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer. Cancers. 15(13). 3397–3397. 6 indexed citations
12.
Čemažar, Maja, et al.. (2022). Electrochemotherapy as an Alternative Treatment Option to Pelvic Exenteration for Recurrent Vulvar Cancer of the Perineum Region. Technology in Cancer Research & Treatment. 21. 2213858377–2213858377. 4 indexed citations
13.
Grošelj, Aleš, Maša Bošnjak, Tanja Jesenko, et al.. (2022). Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol. Radiology and Oncology. 56(3). 398–408. 20 indexed citations
14.
Bošnjak, Maša, et al.. (2022). Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells. Radiology and Oncology. 56(2). 164–172. 7 indexed citations
15.
Bošnjak, Maša, et al.. (2021). PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice. Bioelectrochemistry. 140. 107832–107832. 5 indexed citations
16.
Kos, Špela, Maša Bošnjak, Tanja Jesenko, et al.. (2021). Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study. Pharmaceutics. 13(10). 1739–1739. 12 indexed citations
17.
Jesenko, Tanja, et al.. (2021). Morphological features of breast cancer circulating tumor cells in blood after physical and biological type of isolation. Radiology and Oncology. 55(3). 292–304. 11 indexed citations
18.
Jesenko, Tanja, et al.. (2020). Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer. Cancers. 12(11). 3197–3197. 21 indexed citations
19.
Čemažar, Maja, et al.. (2019). The biology and clinical potential of circulating tumor cells. Radiology and Oncology. 53(2). 131–147. 63 indexed citations
20.
Markelc, Boštjan, Elisabeth Bellard, Gregor Serša, et al.. (2018). Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions. Journal of Controlled Release. 276. 30–41. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026